Search this site:
SORIN GROUP PARTNERS WITH RESPICARDIA, INC., A DEVELOPER OF INNOVATIVE IMPLANTABLE THERAPIES DESIGNED TO IMPROVE RESPIRATORY AND CARDIOVASCULAR HEALTH
Investment will fund on-going clinical testing of the remedē® System for patients with ...
SORIN GROUP: RESIGNATION OF TWO BOARD MEMBERS
Milan, October 17th, 2014 – Sorin S.p.A. has today announced that Roberto Giay and Ugo ...
SORIN GROUP ANNOUNCES FREEDOM SOLO™ CLINICAL RESULTS AT THE 28TH EACTS ANNUAL MEETING
European and North American cohorts study demonstrates safety and excellent clinical and ...
Cardiac Rhythm Management
Working at Sorin
Wake up your talent
Check for jobs